A primary care/multidisciplinary harm reduction clinic including opiate bridging

Substance Use and Misuse

Volumn 43, Issue 11, 2008, Pages 1628-1639

  Ross, David ^a   Lo, Freda ^b   McKim, Robert ^a   Allan, G Michael ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b University of Alberta ^*

Author keywords

Bridging; Dropout; Harm reduction; Methadone; Multidisciplinary; Primary care

Indexed keywords

CODEINE; CODEINE PHOSPHATE; HYDROMORPHONE; METHADONE; OPIATE;

ADDICTION COUNSELLOR; ADULT; ARTICLE; CANADA; CONTROLLED STUDY; DRUG USE; FEMALE; GENERAL PRACTITIONER; HARM REDUCTION; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; METHADONE TREATMENT; NURSE PRACTITIONER; PATIENT CARE; PRIORITY JOURNAL; SOCIAL WORKER; SUBSTANCE ABUSE; HEALTH SERVICES RESEARCH; INTERDISCIPLINARY COMMUNICATION; MEDICAL AUDIT; NONBIOLOGICAL MODEL; OPIATE ADDICTION; OUTPATIENT DEPARTMENT; PATIENT; PRIMARY HEALTH CARE; RISK REDUCTION;

ADULT; ALBERTA; AMBULATORY CARE FACILITIES; FEMALE; HUMANS; INTERDISCIPLINARY COMMUNICATION; MALE; MEDICAL AUDIT; METHADONE; MODELS, ORGANIZATIONAL; OPIOID-RELATED DISORDERS; ORGANIZATIONAL CASE STUDIES; PATIENT DROPOUTS; PRIMARY HEALTH CARE; RISK REDUCTION BEHAVIOR;

EID: 50649115719     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080802241193     Document Type: Article

References (30)

1. Bell, J., Dru, A., Fischer, B., Levit, S., Sarfraz, M. A. (2002). Substitution therapy for heroin addiction. Substance Use and Misuse 37:1149-1178.
2. Broome, K. M., Joe, G. W., Simpson, D. D. (1999). HIV risk reduction in outpatient drug abuse treatment: Individual and geographic differences. AIDS Education and Prevention 11:293-306.
3. Cronquist, A., Edwards, V., Galea, S., Latka, M., Vlahov, D. (2001). Health care utilization among young adult injection drug users in Harlem, New York. Journal of Substance Abuse 13:17-27.
4. Donovan, D. M., Rosengren, D. B., Downey, L., Cox, G. B., Sloan, K. L. (2001). Attrition prevention with individuals awaiting publicly funded drug treatment. Addiction 96:1149-1160.
5. Eder, H., Jagsch, R., Kraigher, D., Primorac, A., Ebner, N., Fischer, G. (2005). Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. Addiction 100:1101-1109.
6. Festinger, D. S., Lamb, R. J., Kountz, M. R., Kirby, K. C., Marlowe, D. (1995). Pretreatment dropout as a function of treatment delay and client variables. Addictive Behaviours 20:111-115.
7. Friedmann, P. D., Hendrickson, J. C., Gerstein, D. R., Zhang, Z., Stein, M. D. (2006). Do mechanisms that link addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care? Medical Care 44:8-15.
8. Friedmann, P. D., Lemon, S. C., Stein, M. D., D'Aunno, T. A. (2003) Accessibility of addiction treatment: Results from a national survey of outpatient abuse treatment organizations. Health Services Research 38:887-903.
9. Gerstein, D. R., Lewin, L.S. (1990). Treating drug problems. New England Journal of Medicine 323:844-848.
10. Gunn, N., White, C., Srinivasan, R. (1998). Primary care as harm reduction for injection drug users. Journal of the American Medical Association 280:1191-1195.
11. Habbard, R. L., Craddock, S. G., Flynn, P. M., Anderson, J., Etheridge, R. M. (1997). Overview of one-year follow-up outcomes in the drug abuse treatment outcome study (DATOS). Psychology of Addictive Behaviours 11:261-278.
12. Hser, Y. I., Magloine, M., Polinsky, M. L., Anglin, M. D. (1998). Predicting drug treatment entry among treatment-seeking individuals. Journal of Substance Abuse Treatment 15:213-220.
13. Krantz, M. J., Mehler, P. S. (2004). Treating opioid dependence. Growing implications for primary care. Archives of Internal Medicine 164:277-288.
14. Krook, A. L., Brors, O., Dahlberg, K., Grouff, K., Magnus, P., Roysamb, E., et al. (2002). A placebo controlled study of high dose buprenorphine in opiate dependentswaiting for medication-assisted rehabilitation in Oslo, Norway. Addiction 97:533-542.
15. Leshner, A. I. (1999). Science-based views of drug addiction and its treatment. Journal of the American Medical Association 282:1314-1316.
16. McLellan, A. T., Lewis, D. C., O'Brien, C. P., Kleber, H. D. (2000). Drug dependence, a chronic medical illness: Implications for treatment, insurance and outcomes evaluations. Journal of the American Medical Association 284:1689-1695.
17. Metzger, D. S., Navaline, H., Woody, G. E. (1998). Drug abuse treatment as AIDS prevention. Public Health Reports 113(1 Suppl):97-106.
18. Metzger, D. S., Woody, G. E., McLellan, A. T., O'Brein, C.P., Druley, P., Navaline, H., et al. (1993). Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An eighteen-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes 6:1049-1056.
19. Mitchell, T. B., White, J. M., Somogyi, A. A., Bochner, F. (2004). Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence. Addiction 99:940-945.
20. O'Connor, P. G., Schottenfeld, R. S. (1998). Patients with alcohol problems. New England Journal of Medicine 338:592-602.
21. Picollo, P., Borg, L., Lin, A., Melia, D., Ho, A., Kreek, M. J. (2002). Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment. Journal of Addictive Diseases 21:55-66.
22. Rosenbaum, M. (1995). The demedicalization of methadone maintenance. Journal of Psychoactive Drugs 27:45-49.
23. Saitz, R., Horton, N. J., Larson, M. J., Winter, M., Samet, J. H. (2005). Primary medical care and reductions in addiction severity: a prospective cohort study. Addiction 100:70-78.
24. Schwartz, R. P., Highfield, D. A., Jaffe, J. H., Brady, J. V., Butler, C. B., Rouse, C. O. (2006). A randomized controlled trial of interim methadone maintenance. Archives of General Psychiatry 63:102-109.
25. Simpson, D. D., Joe, G. W., Rowan-Szal, G. A. (1997). Drug abuse treatment retention and process effects on follow-up outcomes. Drug and Alcohol Dependence 47:227-235.
26. Sindelar, J. L., Fiellin, D. A. (2001). Innovations in treatment for drug abuse: solutions to a public health problem. Annual Review of Public Health 22:249-272.
27. Stark, M. J., Campbell, B. K., Brinkerhoff, C. V. (1990). 'Hello, May we help you?' A study of attrition prevention at the time of the first phone contact with substance-abusing clients. The American Journal of Drug and Alcohol Abuse 16:67-76.
28. Stein, M. D. (1999). Medical consequences of substance abuse. The Psychiatric Clinics of North America 22:351-370.
29. Van de Brink, W., Haasen, C. (2006). Evidence-based treatment of opioid-dependent patients. Canadian Journal of Psychiatry 51:635-646.
30. Wood, E., Li, K., Palepu, A., Marsh, D. C., Schechter, M. T., Hogg, R. S., et al. (2005). Sociodemographic disparities in access to addiction treatment among a cohort of Vancouver injection drug users. Substance Use and Misuse 40:1153-1167.